糖尿病高脂血症:下一代疗法是否需要特别考虑?
Sophie Béliard1,2, Florian Mourre3,4, René Valéro3,4
1APHM (Assistance Publique-Hôpitaux de Marseille), Department of Nutrition, Metabolic Diseases, Endocrinology, La Conception Hospital, Marseille, France. sophie.beliard@ap-hm.fr.
Diabetologia
|February 20, 2024
概括
新的降脂疗法对糖尿病心血管风险有前途. 对于这些先进的治疗方法,有效性和对糖尿病和糖尿病前期患者血糖控制的影响是关键考虑因素.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脱脂症是重要的心血管风险因素,特别是在糖尿病患者中.
- 最近批准的新疗法包括针对脂质颗粒代谢的新疗法,如PCSK9抑制剂和omega-3脂肪酸.
- 人们对使用降脂药物,特别是糖尿病前期患者的新发糖尿病 (NODM) 风险存在担忧.
研究的目的:
- 审查下一代降脂疗法在糖尿病小组中的疗效.
- 评估这些疗法对糖尿病和糖尿病前期患者的血糖控制的影响.
- 评估关于新发型糖尿病的安全概况.
主要方法:
- 审查最近批准和开发的针对脂蛋白代谢的疗法.
- 对临床试验数据的分析,重点关注糖尿病和糖尿病前期患者群体的疗效.
- 检查研究对血糖控制和NODM风险的影响的研究.
主要成果:
- 下一代疗法在降低糖尿病患者心血管风险方面表现出有效性.
- 特定的药物,如icosapent乙烯和PCSK9抑制剂,在相关子组中显示有好处.
- 对于个性化治疗策略,需要仔细考虑NODM风险和血糖控制效应.
结论:
- 新型降脂剂为糖尿病患者的心血管风险管理提供了新的途径.
- 个性化治疗方法至关重要,平衡脂质降低与血糖控制和NODM风险.
- 需要进一步的研究,以充分阐明不同糖尿病人群的长期结果和安全性.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
01:15Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201
01:24Glucagon-like Receptor Agonists
322
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
322
01:24Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
01:18Lipids: Dietary Sources and Requirements
739
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
739